Condition 1: Type 2 Diabetes Mellitus. Condition 2: Erectile Dysfunction. Condition 3: Erectile Dysfunction. Diabetes mellitus due to underlying condition Male erectile dysfunction Male erectile disorder
Conditions
Interventions
Intervention 1: Intervention group: Patients in this group are prescribed 500 mg metformin tablets, one daily for 3 months. According to the duration of the study, 90 tablets are prepared for each per
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: Men between 30 and 70 years of age who have recently been diagnosed with type 2 diabetes during a visit to the Loqman Hakim Hospital clinic Patients whose HbA1c levels were between 6.5 and 8 in the last six months
Exclusion criteria
Exclusion criteria: Patients with a history of diabetes or those who are being treated with blood sugar control drugs Patients who have anatomical disorders in the penis or other sexual disorders Patients with spinal cord injuries Patients who have a stroke Patients who experienced cardiac attack in the past six months Patients who are being treated with mineral nitrates Patients who have peptic ulcers Patients who have migraine Patients who have visual impairment Patients who have allergic rhinitis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Status of erectile dysfunction. Timepoint: Before the study and 90 days after the intervention. Method of measurement: The International Index of Erectile Function questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Body weight. Timepoint: Before the study and 90 days after the intervention. Method of measurement: Body weight scale.;Body mass index. Timepoint: Before the study and 90 days after the intervention. Method of measurement: Calculator.;Systolic blood pressure. Timepoint: Before the study and 90 days after the intervention. Method of measurement: Mercury pressure gauge.;Diastolic blood pressure. Timepoint: Before the study and 90 days after the intervention. Method of measurement: Mercury pressure gauge.;Glycated hemoglobin A1c. Timepoint: Before the study and 90 days after the intervention. Method of measurement: Chromatography.;Fasting Blood Sugar. Timepoint: Before the study and 90 days after intervention. Method of measurement: Photometric method auto analyzer.;Testosterone Serum Level. Timepoint: Before the study and 90 days after the intervention. Method of measurement: ELISA Kit.;Luteinizing hormone Serum Level. Timepoint: Before the study and 90 days after the intervention. Method of measurement: ELISA Kit.;Follicle-Stimulating Hormone Serum Level. Timepoint: Before the study and 90 days after the intervention. Method of measurement: ELISA Kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHooriyeh Talati
Shahid Beheshti University of Medical Sciences
Outcome results
None listed